David J. Arthur - Aug 17, 2021 Form 4 Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role
Chief Executive Officer, Director
Signature
/s/Mark Rosenblum, as Attorney-in-Fac
Stock symbol
SLRX
Transactions as of
Aug 17, 2021
Transactions value $
$3,582
Form type
4
Date filed
8/17/2021, 04:08 PM
Next filing
Nov 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLRX Common Stock Purchase $1.8K +2K +2.04% $0.90 100K Aug 17, 2021 By daughter F1
transaction SLRX Common Stock Purchase $1.78K +2K +2% $0.89 102K Aug 17, 2021 By son F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose